$48.20 0.4%
DOCS Stock Price vs. AI Score
Data gathered: November 23

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - Doximity (DOCS)

Analysis generated May 21, 2024. Powered by Chat GPT.

Doximity, Inc. is a digital health company that operates a professional networking platform for U.S. healthcare professionals. It provides a secure environment for doctors to collaborate with one another, share clinical knowledge, and coordinate patient care. The platform also offers telehealth solutions and clinical workflow tools. With an emphasis on improving efficiency within the healthcare system, Doximity has carved out a unique niche in the market. The company’s goal is to provide solutions that streamline communication in healthcare and ultimately improve patient outcomes.

Read full AI stock Analysis

Stock Alerts - Doximity (DOCS)

company logo Doximity | November 18
Price is up by 5.1% in the last 24h.
company logo Doximity | November 15
Price is down by -5.9% in the last 24h.
company logo Doximity | November 13
Price is down by -5.2% in the last 24h.
company logo Doximity | November 12
Price is down by -6.8% in the last 24h.

About Doximity

Doximity is an online networking service for medical professionals. Launched in 2010, the platform offers its members curated medical news, case collaboration and messaging capabilities.


Doximity
Price $48.20
Target Price Sign up
Volume 2,140,000
Market Cap $8.96B
Year Range $22.99 - $61.25
Dividend Yield 0%
PE Ratio 55.17
Analyst Rating 31% buy
Industry Digital health

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '24137M14M123M44M54M0.300
Q2 '24127M14M113M41M47M0.280
Q1 '24118M13M105M41M43M0.250
Q4 '23135M12M123M48M60M0.290
Q3 '23114M13M101M31M35M0.220

Insider Transactions View All

Wampler Kira Scherer filed to sell 16,618 shares at $42.
November 4 '24
Cabral Timothy S filed to sell 11,074 shares at $42.1.
November 4 '24
Wampler Kira Scherer filed to sell 16,618 shares at $43.4.
October 2 '24
Wampler Kira Scherer filed to sell 16,618 shares at $36.3.
September 5 '24
Bryson Anna filed to sell 317,942 shares at $35.5.
August 15 '24

What is the Market Cap of Doximity?

The Market Cap of Doximity is $8.96B.

What is Doximity's PE Ratio?

As of today, Doximity's PE (Price to Earnings) ratio is 55.17.

What is the current stock price of Doximity?

Currently, the price of one share of Doximity stock is $48.20.

How can I analyze the DOCS stock price chart for investment decisions?

The DOCS stock price chart above provides a comprehensive visual representation of Doximity's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Doximity shares. Our platform offers an up-to-date DOCS stock price chart, along with technical data analysis and alternative data insights.

Does DOCS offer dividends to its shareholders?

As of our latest update, Doximity (DOCS) does not offer dividends to its shareholders. Investors interested in Doximity should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Doximity?

Some of the similar stocks of Doximity are Teladoc Health, Veeva Systems, GoodRx, Lifestance Health, and Amwell.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.